Colfosceril Palmitate
Overview
Rifabutin is rifamycin antibiotic with a spectrum of antibacterial activity similar to that of rifampicin. Rifabutin is used for the prophylaxis of Mycobacterium avium complex (MAC) infection in immunocompromised patients and for the treatment of opportunistic mycobacterial infections including tuberculosis (T.B).
Categories
- 25 Drugs acting on the respiratory tract
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Colfosceril Palmitate's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 5 ml/kg | 5 (5) | As recommended. | IV | Prophylactic treatment: 1st dose should be given after birth and 2nd and 3rd dose is given 12 and 24 hours later to infants. |
Paedriatic Dosage (20kg)
|
| No data regarding the Paedriatic dosage details of Colfosceril Palmitate is available. |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Colfosceril Palmitate is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Colfosceril Palmitate
Back to top
Manufacturers of
Colfosceril Palmitate
in Pakistan
Back to top
Previous Drug Generic - Next Drug Generic